Welcome to Penn Vet’s new website; now in the last phase of completion. If you are a member of the Penn Vet community and see an issue, please complete our feedback form.

    Dr. Mason’s background is an immunologist, but her getting a postdoc at a cancer-focused lab that shaped her career and research interests. Mason focuses on bone cancer in dogs, a disease which affects 15,000 plus large dogs a year — and has remarkable parallels to osteosarcomas in humans.

    Dr. Mason’s interests stretch beyond bone cancers, and into a variety of other cancers that are being researched in her lab, and beyond into other diseases that may have potential immunotherapeutic treatment options. Mason also leads PRECINCT (PRE-medical Cancer Immunotherapy Network Canine Trials), a network of research centers supported by National Cancer Institute’s Cancer Moonshot to work on next-generation immunotherapies on dogs that may one day help humans.

    With your help, we can accomplish our goals more successfully and more quickly. Play a part in the next breakthrough immunotherapy treatment Dr. Mason and her team develop to treat canine cancers and save lives. You can contribute in the following ways:

    Harley